Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 105701-105750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04064359
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
PHASE1Recruiting
200 participants
Started: Jul 25, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor27 locations
NCT03909334
Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
PHASE2Active, not recruiting
160 participants
Started: Jul 25, 2019 · Completed: Jan 31, 2026
4 conditions3 sponsors12 locations
NCT03821129
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
NARecruiting
636 participants
Started: Jul 25, 2019 · Completed: Oct 31, 2031
2 conditions1 sponsor44 locations
NCT03737994
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
PHASE2Active, not recruiting
10 participants
Started: Jul 25, 2019 · Completed: Dec 2, 2025
4 conditions2 sponsors491 locations
NCT04039750
Use of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis
PHASE2Active, not recruiting
200 participants
Started: Jul 25, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03904862
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
PHASE1/PHASE2Active, not recruiting
66 participants
Started: Jul 25, 2019 · Completed: Feb 21, 2030
3 conditions4 sponsors12 locations
NCT03836014
Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
PHASE3Active, not recruiting
436 participants
Started: Jul 25, 2019 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT03999229
S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion
PHASE1Recruiting
35 participants
Started: Jul 25, 2019 · Completed: Feb 29, 2028
1 condition3 sponsors1 location
NCT03799445
Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma
PHASE2Active, not recruiting
37 participants
Started: Jul 25, 2019 · Completed: Jun 30, 2026
11 conditions2 sponsors1 location
NCT04184687
The Treatment of Cartilaginous Lesions and Concomitant Anterior Cruciate Ligament Reconstruction
NARecruiting
88 participants
Started: Jul 25, 2019 · Completed: Jul 25, 2027
2 conditions1 sponsor1 location
NCT03857620
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer
NAActive, not recruiting
325 participants
Started: Jul 24, 2019 · Completed: Oct 31, 2025
4 conditions2 sponsors44 locations
NCT03679221
Motoric Cognitive Risk and Depression
N/AActive, not recruiting
30,000 participants
Started: Jul 24, 2019 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT04038983
Risk for Short-term Adverse Events in Older Users in the Emergency Department
N/AActive, not recruiting
10,000 participants
Started: Jul 24, 2019 · Completed: Jan 30, 2025
3 conditions1 sponsor1 location
NCT03872778
[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake
PHASE1/PHASE2Active, not recruiting
51 participants
Started: Jul 24, 2019 · Completed: Dec 1, 2026
1 condition1 sponsor11 locations
NCT04082533
Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)
PHASE4Active, not recruiting
132 participants
Started: Jul 24, 2019 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT03876223
Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF
N/ARecruiting
180 participants
Started: Jul 24, 2019 · Completed: Feb 28, 2026
2 conditions2 sponsors2 locations
NCT03884075
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
PHASE2Recruiting
84 participants
Started: Jul 24, 2019 · Completed: Oct 2, 2026
2 conditions2 sponsors1 location
NCT04040387
Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken)
NAEnrolling by invitation
270 participants
Started: Jul 24, 2019 · Completed: Aug 24, 2024
6 conditions5 sponsors4 locations
NCT03924895
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
PHASE3Active, not recruiting
595 participants
Started: Jul 24, 2019 · Completed: Dec 15, 2027
1 condition3 sponsors242 locations
NCT03779490
Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND)
N/AActive, not recruiting
150 participants
Started: Jul 24, 2019 · Completed: Dec 31, 2027
2 conditions1 sponsor14 locations
NCT06400225
Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic Changes (MATCH - Subprotocol Z1L)
PHASE2Active, not recruiting
35 participants
Started: Jul 24, 2019 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT03965676
Evolution of Tophus and Erosions of Hands and Feet at DECT
NAActive, not recruiting
50 participants
Started: Jul 24, 2019 · Completed: Oct 11, 2025
1 condition2 sponsors2 locations
NCT04143607
ASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or Metastatic NSCLC
PHASE3Active, not recruiting
337 participants
Started: Jul 23, 2019 · Completed: Sep 30, 2026
1 condition1 sponsor3 locations
NCT03978650
Risk Factors for Falls and Fall-related Injuries Associated With Mild Neurocognitive Disorders
N/AActive, not recruiting
12,000 participants
Started: Jul 23, 2019 · Completed: Jan 1, 2026
3 conditions1 sponsor1 location
NCT03977194
Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy
PHASE3Active, not recruiting
500 participants
Started: Jul 23, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor68 locations
NCT03534947
A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma
PHASE2Recruiting
20 participants
Started: Jul 23, 2019 · Completed: Jun 30, 2025
4 conditions1 sponsor1 location
NCT06276036
Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.
NAActive, not recruiting
53 participants
Started: Jul 23, 2019 · Completed: Jun 1, 2025
1 condition1 sponsor6 locations
NCT04344899
Pediatric Oncology Recovery Trial After Surgery
N/ARecruiting
288 participants
Started: Jul 23, 2019 · Completed: Jan 31, 2028
1 condition1 sponsor3 locations
NCT03957382
Evaluation of Safety and Efficacy of the Accero® (Heal) Stent for Intracranial Aneurysm Treatment
N/ARecruiting
130 participants
Started: Jul 23, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT04024540
Isocaloric Dietary Restriction vs. Bariatric Surgery for Obesity Treatment
NAActive, not recruiting
72 participants
Started: Jul 23, 2019 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT03945552
Pediatric Parenting Support in Flint
NAActive, not recruiting
486 participants
Started: Jul 23, 2019 · Completed: Feb 28, 2026
2 conditions5 sponsors2 locations
NCT03654105
Screening and Multiple Intervention on Lung Epidemics
PHASE2Active, not recruiting
2,000 participants
Started: Jul 23, 2019 · Completed: Dec 31, 2026
5 conditions2 sponsors1 location
NCT03916627
Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients
PHASE2Active, not recruiting
65 participants
Started: Jul 23, 2019 · Completed: May 14, 2030
3 conditions1 sponsor1 location
NCT04017273
Older Emergency Department Users and Hospitalization After an Index Visit: Results of ER2 Database
N/AActive, not recruiting
10,971 participants
Started: Jul 23, 2019 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT04758325
The Sarcoma Biology and Outcome Project
N/ARecruiting
3,000 participants
Started: Jul 23, 2019 · Completed: Dec 31, 2032
3 conditions1 sponsor1 location
NCT04034264
Febrile Disease Landscape in Cambodia Via Metagenomic Pathogen Sequencing
N/ARecruiting
6,500 participants
Started: Jul 23, 2019 · Completed: Jul 1, 2026
2 conditions1 sponsor6 locations
NCT04014829
Evaluation of Central Sensitization, Fear-Avoidance, and Pain-Pressure Threshold With Chronic Pain After Hysterectomy
N/ARecruiting
436 participants
Started: Jul 23, 2019 · Completed: Dec 31, 2027
4 conditions1 sponsor1 location
NCT03628768
Risk Factors for Falls and Neurocognitive Disorders CLSA
N/AActive, not recruiting
12,000 participants
Started: Jul 23, 2019 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT04212910
Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model
N/ARecruiting
101 participants
Started: Jul 23, 2019 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT03962972
Association of Centre of Excellence Self-Administered Questionnaire (CESAM) Score and Frailty Levels
N/AActive, not recruiting
1,741 participants
Started: Jul 23, 2019 · Completed: Jan 1, 2025
3 conditions1 sponsor1 location
NCT03899337
A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome
PHASE2Recruiting
105 participants
Started: Jul 23, 2019 · Completed: May 31, 2027
1 condition3 sponsors16 locations
NCT04022551
Emergency Room Evaluation and Recommendations for Older Users of Emergency Departments
N/AActive, not recruiting
4,724 participants
Started: Jul 23, 2019 · Completed: Sep 1, 2024
3 conditions1 sponsor1 location
NCT03610802
Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies
N/ARecruiting
3,000 participants
Started: Jul 22, 2019 · Completed: Mar 31, 2038
1 condition1 sponsor3 locations
NCT04046445
Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
PHASE1Active, not recruiting
96 participants
Started: Jul 22, 2019 · Completed: Aug 31, 2025
6 conditions2 sponsors12 locations
NCT02910414
TARGET BP I Clinical Trial
PHASE3Active, not recruiting
300 participants
Started: Jul 22, 2019 · Completed: May 31, 2026
1 condition1 sponsor5 locations
NCT04206540
Effect of Stimulation on the Vagus Nerve
NAActive, not recruiting
30 participants
Started: Jul 22, 2019 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT03935139
Monitoring of the Bone Free Flaps With Microdialysis
NARecruiting
40 participants
Started: Jul 22, 2019 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT04110522
Psoriatic Arthritis D2P Screening
NARecruiting
18,000 participants
Started: Jul 22, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT03844750
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases
PHASE2Active, not recruiting
6 participants
Started: Jul 22, 2019 · Completed: Apr 30, 2026
5 conditions3 sponsors1 location
NCT04021108
Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)
PHASE2Active, not recruiting
80 participants
Started: Jul 22, 2019 · Completed: Jun 30, 2026
1 condition2 sponsors5 locations